204 related articles for article (PubMed ID: 2308991)
1. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
Rowley S; Davis J; Braine H; Jones R; Yeager A; Saral R; Santos G
Prog Clin Biol Res; 1990; 333():369-77. PubMed ID: 2308991
[TBL] [Abstract][Full Text] [Related]
2. Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamide.
Rowley SD; Davis JM; Piantadosi S; Jones RJ; Yeager AM; Santos GW
Bone Marrow Transplant; 1990 Nov; 6(5):321-7. PubMed ID: 2291993
[TBL] [Abstract][Full Text] [Related]
3. Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
Iacone A; Quaglietta AM; D'Antonio D; Accorsi P; Dragani A; Angrilli F; Berardi A; Angelini A; Di Bartolomeo P; Di Bartolomeo G
Haematologica; 1991 Mar; 76 Suppl 1():18-21. PubMed ID: 1677910
[TBL] [Abstract][Full Text] [Related]
4. Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30.
Humblet Y; Lefebvre P; Jacques JL; Bosly A; Feyens AM; Sekhavat M; Agaliotis D; Symann M
Bone Marrow Transplant; 1988 Jan; 3(1):63-7. PubMed ID: 2901880
[TBL] [Abstract][Full Text] [Related]
5. Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow.
Schanz U; Gmür J
Bone Marrow Transplant; 1992 Dec; 10(6):507-13. PubMed ID: 1490200
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedure.
Pierelli L; Menichella G; Serafini R; de Martini M; Paoloni A; Foddai ML; Scambia G; Benedetti Panici PL; Mancuso S; Leone G
Bone Marrow Transplant; 1991 May; 7(5):355-61. PubMed ID: 2070144
[TBL] [Abstract][Full Text] [Related]
7. Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separator.
Wiesneth M; Hertenstein B; Koerner K; Heimpel H; Heit W
Beitr Infusionsther; 1988; 21():340-5. PubMed ID: 2463006
[TBL] [Abstract][Full Text] [Related]
8. Human bone marrow processing using Cobe 2991 and CS 3000 blood cell separators for further ex vivo manipulation.
Angelini A; Dragani A; Iacone A; D'Antonio D; Accorsi P; Quaglietta AM; Berardi A; Fioritoni G; Di Bartolomeo P; D'Emilio G
Haematologica; 1990; 75 Suppl 1():43-7. PubMed ID: 2351343
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
10. T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cells.
Olivero S; Novakovitch G; Ladaique P; Sainty D; Viret F; Faucher C; Stoppa AM; Blaise D; Chabannon C
Cytotherapy; 1999; 1(6):469-77. PubMed ID: 20443236
[TBL] [Abstract][Full Text] [Related]
11. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte removal from bone marrow by density gradient separation using the COBE 2991 cell processor with the triple-bag processing set].
Cappellesso-Fleury S; Rage C; Tschaggeny F; Gaudé J; Gomez M; Bourin P
Transfus Clin Biol; 2009 Mar; 16(1):43-9. PubMed ID: 19200762
[TBL] [Abstract][Full Text] [Related]
13. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
Rowley SD; Piantadosi S; Santos GW
Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
[TBL] [Abstract][Full Text] [Related]
14. Rapid and safe automated processing of bone marrow grafts without using density gradient cryopreservation and transplantation.
Deméocq F; Kanold J; Bezou MJ; Travade P; Chassagne J; Berger M
Prog Clin Biol Res; 1994; 389():675-84. PubMed ID: 7700935
[No Abstract] [Full Text] [Related]
15. Comparison of progenitor cell concentration techniques: continuous flow separation versus density-gradient isolation.
Davis JM; Schepers KG; Eby LL; Noga SJ
J Hematother; 1993; 2(3):315-20. PubMed ID: 7921992
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557).
Douay L; Mary JY; Giarratana MC; Najman A; Gorin NC
Exp Hematol; 1989 Jun; 17(5):429-32. PubMed ID: 2653856
[TBL] [Abstract][Full Text] [Related]
17. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
Giarratana MC; Gorin NC; Douay L
Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
[TBL] [Abstract][Full Text] [Related]
18. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
Hervé P; Flesch M
Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow processing on the Haemonetics V50 cell separator.
Anderson NA; Cornish JM; Godwin V; Gunstone MJ; Oakhill A; Pamphilon DH
Transfus Sci; 1990; 11(2):201-4. PubMed ID: 10149526
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation.
Kies MS; Gordon LI; Rosen ST; Kucuk O; Vriesendorp HM
Exp Hematol; 1988 Mar; 16(3):190-4. PubMed ID: 3276545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
